ThPO overexpression in HSPCs first leads to leukocytosis and thrombocytosis and, over time, with onset of fibrosis, reduced hemoglobin and erythrocyte counts (Fig. 2f and Extended Data Fig. 5a). The gene discussed is THPO; the disease is thrombocytosis disease.